Instil Bio Q2 FY26 net loss per share narrows to $0.63 from year-ago $3.24 - TIL News | RalliesInstil Bio Q2 FY26 net loss per share narrows to $0.63 from year-ago $3.24
T
TIL• Cash position and outlook
- Cash, cash equivalents, restricted cash and marketable securities totaled $69.9 million at June 30, down from $76.3 million at Dec. 31.
- Instil is evaluating potential acquisitions and in-licensing opportunities, forecasting its cash runway extends beyond 2027.
Q2 FY26 earnings and expenses
- Instil Bio posted a GAAP net loss per share of $0.63 for Q2 2026, narrowing from $3.24 a year earlier.
- Non-GAAP net loss per share was $0.45, improving from $2.88 in the prior-year quarter.
- R&D expense fell to $0.3 million from $6.7 million, while G&A declined to $5.1 million from $6.2 million.
•
